Who founded Kanvas Bio?

Kanvas Bio was founded by Matthew Cheng, Hao Shi, Iwijn De Vlaminck in 2020.

Who are Kanvas Bio's investors?

Kanvas Bio's investors include Bascom Ventures, Boutique Venture Partners, DCVC (Data Collective), FemHealth Ventures, Germin8 Ventures, Kicker Ventures, Pangaea Ventures Us Inc., Red Bear Ventures and 1 more.

How much funding has Kanvas Bio raised?

Kanvas Bio has disclosed $15.7M raised across 2 rounds.

Where is Kanvas Bio headquartered?

Kanvas Bio is headquartered in Monmouth Junction, US.

Kanvas Bio

Monmouth Junction, US · Founded 2020 · 9 known investors

kanvasbio.com ↗

Kanvas Bio operates a full-stack microbiome drug discovery platform, using a spatial mapping engine to image host-microbiome interactions and in-house manufacturing to produce live biotherapeutics. Its therapies are designed to modulate host immunity for applications including immunotherapy and malnutrition treatments.

Biotech Deep Tech Healthtech

Founders & leadership

Kanvas Bio was founded in 2020 by Matthew Cheng, Hao Shi, and Iwijn De Vlaminck.

Matthew ChengCo-founder

Hao ShiCo-founder

Iwijn De VlaminckCo-founder

Board

Jason Pontin in 𝕏Board ChairGeneral Partner at DCVC (Data Collective)

Justin Smithline inBoard directorGeneral Partner at Triple Impact Capital

Investors · 9

Bascom VenturesBoston

Boutique Venture PartnersPalo Alto

DCVC (Data Collective)Palo Alto · $5M – $25M

FemHealth VenturesShort Hills

Germin8 VenturesChicago

Kicker VenturesMenlo Park · $100K – $1Mvia Masashi Kiyomine · inferred

Pangaea Ventures Us Inc.Vancouver · $500K – $1.5M

Red Bear VenturesIthaca · $200K – $1.3M

Triple Impact CapitalreportedSan Francisco · $250K – $600Kvia Justin Smithline · board

Reported raises · per SEC filings

Form D private placements

$15.7M disclosed across 2 rounds · 2023–2024

▶$3.9MraisedMar 2024 · 54 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Paul TheunissenDirector
Jason PontinDirector
Matthew ChengExecutive Officer, Director
Hao ShiExecutive Officer, Director

Offering amount: $10M
Amount sold: $3.9M
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$11.8MraisedJun 2023 · 12 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Jason PontinDirector
Matthew ChengExecutive Officer, Director
Hao ShiExecutive Officer, Director
Iwijn De VlaminckExecutive Officer, Director
Justin SmithlineDirector

Offering amount: $12M
Amount sold: $11.8M
First sale: Jun 2023
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Kanvas Biosciences, Inc. - BIO International Convention 2026convention.bio.org

Frequently asked questions

What does Kanvas Bio do?: Kanvas Bio operates a full-stack microbiome drug discovery platform, using a spatial mapping engine to image host-microbiome interactions and in-house manufacturing to produce live biotherapeutics. Its therapies are designed to modulate host immunity for applications including immunotherapy and malnutrition treatments.
Who founded Kanvas Bio?: Kanvas Bio was founded by Matthew Cheng, Hao Shi, Iwijn De Vlaminck in 2020.
Who are Kanvas Bio's investors?: Kanvas Bio's investors include Bascom Ventures, Boutique Venture Partners, DCVC (Data Collective), FemHealth Ventures, Germin8 Ventures, Kicker Ventures, Pangaea Ventures Us Inc., Red Bear Ventures and 1 more.
How much funding has Kanvas Bio raised?: Kanvas Bio has disclosed $15.7M raised across 2 rounds.
Where is Kanvas Bio headquartered?: Kanvas Bio is headquartered in Monmouth Junction, US.